Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

16 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/16/3206636/0/en/Solid-Biosciences-Announces-Duchenne-Muscular-Dystrophy-Added-to-National-Recommended-Uniform-Screening-Panel-by-the-U-S-Department-of-Health-and-Human-Services.html

01 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/01/3197428/0/en/Solid-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

01 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/01/3196939/0/en/Solid-Biosciences-Receives-FDA-Rare-Pediatric-Disease-Designation-for-SGT-212-Dual-Route-of-Administration-Gene-Therapy-for-Friedreich-s-Ataxia.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189051/0/en/Solid-Biosciences-Announces-Licensing-Agreement-with-Andelyn-Biosciences-for-the-Use-of-Proprietary-Next-Generation-Capsid-AAV-SLB101.html

11 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/11/3185347/0/en/Solid-Biosciences-to-Participate-at-Upcoming-Investor-Conferences.html

06 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/06/3182474/0/en/Solid-Biosciences-Awarded-Innovation-Passport-Designation-Under-the-New-UK-Innovative-Licensing-and-Access-Pathway-for-SGT-003-an-Investigational-Gene-Therapy-for-Duchenne-Muscular.html
ABOUT THIS PAGE